Boehringer Ingelheim to supply free smart health connected inhalers

[ad_1]

Boehringer Ingelheim, the German pharmaceutical giant, which has no fewer than 45 branches worldwide, has decided to supply a number of its smart health connected inhalers to patients in need. In this way, they will be able to benefit from a complete health follow-up between appointments and more clearly identify the triggers of asthma attacks.

When new technologies and social work come together to allow a whole class of disadvantaged people to benefit from the latest generation of care, it gives hope for the future. According to spokespersons for Boehringer Ingelheim, these are more than 2,500 patients who would be affected by this news. Focus on a pharmaceutical industry, certainly international, but human above all.

Boehringer Ingelheim offers an extensive healthcare access plan

It's at Rushin Kansal, the director of business innovation for life sciences, digital health and healthcare systems, that we owe this beautiful humanist idea. Concretely, it is thanks to the twinning of the company which developed the smart health connected inhalers, Propeller Health, with Boehringer Ingelheim that the idea germinated. From this partnership, Boehringer Ingelheim finances the marketing of Respimat smart health connected inhalers, and from this exchange, patients will be able to sign up for free health programs.

The advantage of such a system is two-way, on the patient side, they benefit from day-to-day monitoring of their illness, while in the pharmaceutical industry, this allows them to be able to study the triggers of respiratory diseases and thus to be able to propose new solutions to fight against these diseases, which are unfortunately quite widespread.

Operation of the Respimat smart health connected inhaler

The real asset of the Respimat smart health connected inhaler, designed by Propeller Health, lies in its ability to record the medication taken, by time and place, in this way doctors can have an overview of the state of health and the consumption of medication by patients between each appointment . In addition, an associated application supports users of the inhaler.

It is one of the first times that the pharmaceutical industry, which is usually very closed in on itself, opens up to combine research on diseases and free access to the latest generation of medicines. So let's hope that this collaboration is the first of a long series of others … Especially in the smart health connected healthcare, many startups are trying to offer new solutions to treat or facilitate the life of certain chronic patients, such as smart health connected glucometers for example.

[ad_2]